linkedin
facebook
Twitter
Youtube
 
For the 7th time on 22-23 February 2017  
*****Corinthia Hotel Budapest, Hungary Login to meeting scheduler demo CZE ENG HUN POL ROU
PHARM Connect Programme & Speakers
vr

PHARM Connect Congress 2017 will bring you an overview of the Central Eastern European market and the main trends and impacts on the pharmaceutical manufacturing & biotechnology world.

For speaking opportunities please contact Katy Säurich Operations & Production Manager at TEG or Tel: + 36 1 219-5725.

 

PHARM Connect Congress programme 2017

Keynote Presentation: Industry 4.0 and Single Use Technology in BioPharma

Dirk Tillich, European Sales Director, Finesse Solutions
  • The 4th Industrial Revolution
  • Improving Competitiveness 
  • Impact for BioPharma
  • Continuous Manufacturing
  • Examples of implemented Smart Factories

Dirk Tillich, VP Global Sales, Core Business, Finesse Solutions

 

 Keynote Presentation: EU’s Falsified Medicines Directive (FMD): How to prepare now for the 2019 deadline?

Neil Lawrence, Global Serialisation Champion, Global Manufacturing and Supply, GlaxoSmithKline
  • Preparing for compliance: How to protect the market?
  • Global look at Big Pharma business-critical practicalities of serialisation
  • GSK best practice case study and lessons learnt 

Neil Lawrence, Global Serialisation Champion, Global Manufacturing and Supply, GlaxoSmithKline

 

Case Study PresentationNew Equipment and Equipment Substitutes – Best Practices of Integration and Process Validation

Dr. János Dombovári, Director Operational Excellence Pharma Division, TEVA Pharmaceuticals Works
  • Considerations during tablet press substitution: how to integrate the new machine into the existing production system and how to validate operation
  • How to handle differences and analogies
  • Incorporation of technical improvements into the production process

Dr. János Dombovári, Director Operational Excellence Pharma Division, TEVA Pharmaceuticals Works

 

Presentation: Regulatory and quality management system changes in Russian Pharma market: Recent developments and future perspective  

Ekaterina Tvorogova, Regulatory Affairs Manager, Egis Pharmaceuticals, Representation in Russia
  • The impact of main regulatory requirements on drugs turnover
           - Local clinical trials,Russian GMP inspections,
           - State quality control system,
           - Price regulation.  
  • Eurasian Union pharmaceutical market. What exactly was introduced and what are the expectations?

Ekaterina Tvorogova, Regulatory Affairs Manager, Egis Pharmaceuticals, Representation in Russia

 

Case Study Presentation: Challenges in meeting Good practices for data management and integrity in regulated GMP environments guidance

Dr. Piotr Lipinski, Quality Systems Manager/QP, Novartis Technical Operations - Platform Solids Europe, Lek / Sandoz
  • General requirements related to data integrity
  • Main FDA and EU inspections observations in scope of data management and integrity
  • Data management and Integrity program for pharmaceutical company

Dr. Piotr Lipinski, Quality Systems Manager/QP, Novartis Technical Operations - Platform Solids Europe, Lek / Novartis

 

Presentation: Concepts to improve the productivity of drug innovation 

Professor Péter Mátyus, Director of the Drug Discovery and Safety Centre and CEO of the Bionics Innovation Center, Semmelweis University Budapest
  • Trends in performance of drug innovation, an overview
  • Limitations of productivity
  • Some principles for (more) effective preclinical research
  • The possible contributions of University to drug discovery
  • Case studies

Professor Péter Mátyus, Director of the Drug Discovery and Safety Centre and CEO of the Bionics Innovation Center, Semmelweis University Budapest

 

Case Study Presentation: Discover Pall’s full mAb Purification Platform 

Adriane Raninger, Bio-Purification Process Specialist CEE, Pall Life Sciences

The presentation illustrates recent evolutions in Bioprocessing and describes in detail all potential opportunities for a process platform run in continuous mode. The content rounds up with an overview of selected Pall products and gives useful application details in Downstream Processing.  

Adriane Raninger, Bio-Purification Process Specialist CEE, Pall Life Sciences

 

Presentation: Efficiency increase for single-use cell removal (Midstream) using filter aid and continuous process design

Ralph Daumke, Market Manager Biologics, FILTROX
  • Increasing cell removal efficiency
  • Continuous process
  • Cost effective process

Ralph Daumke, Market Manager Biologics, FILTROX  

 

 

Panel Discussion: EU’s Falsified Medicines Directive (FMD): How to protect the market?

 

Grzegorz Brzoskowski, Security Director CEE / Baltic, SANOFI

Kees Middelkoop, Director Supply Chain & Regional serialization lead Europe, Amgen

Réka Balogh, Leader of the Safety Feature Committee of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) & Serialization Project Coordinator, Quality Assurance Expert, TQM, Gedeon Richter Neil Lawrence, Global serialization Champion, Global Manufacturing and Supply, GlaxoSmithKline

Grzegorz Brzoskowski,

Security Director CEE / Baltic,

SANOFI

Kees Middelkoop,

Director Supply Chain & Regional serialization lead Europe,

Amgen (tbc) 

 

Réka Balogh,

Leader of Safety Feature Committee MAGYOSZ &

Serialization Project Coordinator, QA Expert, TQM,

Gedeon Richter 

 

Neil Lawrence,

Global serialization Champion, Global Manufacturing and Supply,

GlaxoSmithKline 

 

 

 

 

Project Presentations by the Award Winners of the 3rd CEE Pharmaceutical Manufacturing Excellence Award

The award has been established to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. Manufacturers as well as solution providers are welcome to apply with their most innovative projects and methods implemented in the region. The winners will have the opportunity to present their projects at PHARM Connect 2017.


Applications should be submitted by 16th of January 2017 and will be assessed by our highly renowned independent regional academic jury.

Due to the overwhelming interest from the market we have decided to extend the

deadline to the 31st January 2017!!!


Further information click here

 

 

Additional Networking Activities

 Site visit to the GlaxoSmithKline Biologicals plant 

The congress provides the opportunity to visit GlaxoSmithKline Biologicals in Gödöllő limited for 50 delegates only and available on a first come first serve complimentary basis on February 21st at 1:00 p.m.

GlaxoSmithKline Biologicals Kft. is located in Gödöllő and is part of the GlaxoSmithKline Vaccines business branch. At the Gödöllő site GSK is producing, testing and releasing Tetanus and Diphtheria bulk antigens for shipment to other GSK Vaccines sites. About 220 people are involved in the manufacturing of antigens used in vaccines such as Synflorix™, Menitorix™, Hiberix™, and MenHibrix™. The Gödöllő site contributes to the 12% of the annual turn-over of GSK Vaccines.

The visit of the site will provide an opportunity to get more information about the activities of the Gödöllő site, the vaccine manufacturing process and the manufacturing facility of the biotechnology site. The site visit will start with an introduction of the GSK Vaccines business division and the Gödöllő site, including a short movie about the activities which is followed by a site tour including a visit to the manufacturing facility.

Delegates can select among the following three focus groups: 

  • Group A: production corridor, Biochemistry lab and warehouse
  • Group B: warehouse, production corridor, Microbiology lab
  • Group C: Microbiology lab, warehouse and production corridor

As for the outfit, jeans and comfortable shoes are required. Helmet is needed in warehouse, gowning (coat) in Biochemistry lab, gowning (coat) and shoe cover are needed in the Micobiology lab and will be provided before the visit.

Transfer: The bus will leave in front of the Corinthia Grand Hotel Royal on February 21st at 12:00 p.m. and will return after the visit at approximately 5:00 p.m.

 


Additional Networking Activities – Site visit to the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK)

 Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK) 

The congress provides the opportunity to visit the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK) in Budapest limited for 60 delegates only and available on a first come first serve complimentary basis on February 23rd at 5:00 p.m. The MTA Research Centre for Natural Sciences carries out multidisciplinary research in natural sciences.  Priorities are given to the following disciplines:

-          Organic chemistry

-          Materials- and environmental chemistry

-          Molecular and cellular life sciences

-          Cognitive neuroscience and psychology

 

The visit will start with a short introductory presentation about the MTA TTK. Afterwards the delegates will have the opportunity choose a tour among the four research institutes:

 

Organic chemistry

Developing novel types of reaction, the synthesis of new ring frames and compounds in the field of organic small- and supramolecular molecules, determination of chemical structure and interpretation of experimental processes by instrumental techniques and theoretical calculations. 

 

Materials- and environmental chemistry

Research of discovery and experimental development in some key areas of materials- and environmental science, with special emphasis on chemical aspects thereof. Exploratory research in the field of nanoscale functional materials and application of the results in integrated nano/micro systems.

 

Enzymology

Researchers at the Institute of Enzymology investigate the structure of proteins and how they function – at the level of molecules through to complex organisms. They make use of the latest biochemical, imaging and genetic engineering methods to reveal the structure of proteins, their properties and the biological functions enzymes perform in the human body. Further important areas of research are signal processing and transmission, the regulation of protein breakdown and how cancer evolves. The researchers also want to find out what the actual protein composition of the cell looks like and how complete biological systems function. Target based drug development.

 

Cognitive neuroscience and psychology

Research of discovery and applications in experimental psychology, human-, developmental and comparative psychophysiology, social development psychology, social psychology and cultural psychology. 

 

Transfer: The bus will leave in front of the CORINTHIA Grand Hotel Royal on February 23rd at 4:00 p.m. and will return after the visit at approximately 8:00 p.m.

 

 

For speaking opportunities please contact: Katy Säurich Head of Operations & Production at TEG

Tel: + 36 1 219-5725

vr
Sponsors
vr
Pall Life Sciences
Finesse Solutions
FILOTROX
GSK Vaccines

Exclusive Excursion Partner

MTA TTK

Exclusive Excursion Partner

View more

vr
Sample list of sponsors
vr

View more

vr
Partners
vr

Lead Association Partner

Hungarian Pharmaceutical Manufacturers Association

View more


Exclusive Hungarian Media Partner

MarketingPirula- PirulaTrend

View more

vr
The Events Group | More Information | Contact Us | BOOK NOW
TheEventsGroup © 2012 | Privacy Policy | Terms Of Use
Design: Nortyx Program: Nortyx Web and Recording studio, Stage technic